<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders">ORC-21 Ordering Facility Name #01311 (HL7)<br/>Path Ordering Facility Number (AHA Number)</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">7191</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">25</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">HL7</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">4702-4726</td>
    </tr>
</table>

<br/><b>Description</b><br/>
Facility ID number of the facility where the specimen described in the second path report was removed/collected. <br/>
<br/>
Use the National Provider Identifier (NPI) if possible. Otherwise, use a number defined by the American Hospital Association (AHA), or some other standard-setting organization such as the American College of Surgeons (ACoS) or Clinical Laboratory Improvement Amendments (CLIA).<br/>
<br/>
This item accommodates only one path report; if additional path reports were prepared, enter the facility ID number(s) in Path Ordering Fac No 3 through Path Ordering Fac No 5 [7192-7194]. Information in this data item should refer to the path report described in data items 7011, 7091, 7101, and 7481.

<br/><br/><b>Rationale</b><br/>
Describes the origin of the second pathology report contributing to this cancer abstract. The facility where the specimen was obtained is most likely the location of the medical record for the patient as well as any residual tissue.

